09:18 AM EST - MYND Life Sciences Inc. : Announced the formation of its scientific advisory board ("SAB"). The SAB is comprised of international industry experts and pioneers in the fields of neuropsychopharmacology, genetics, immunology, psychedelics, medical research, and clinical trials. "We are incredibly excited about the roster of advisors we have been able to attract to MYND's scientific advisory board," stated Dr. Lyle Oberg , MYND's Chief Executive Officer. "We have continued to believe that the science and patents being advanced and refined by MYND's Dr. Wilfred Jefferies and his team could attract the most pre-eminent and distinguished minds in science from across the globe, and the advisory board we have assembled thus far serves to validate our enthusiasm," continued Dr. Oberg. MYND Life Sciences Inc.
shares C.MYND are trading unchanged at $2.15.
